PBYI vs. SPY
Compare and contrast key facts about Puma Biotechnology, Inc. (PBYI) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PBYI or SPY.
Correlation
The correlation between PBYI and SPY is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PBYI vs. SPY - Performance Comparison
Key characteristics
PBYI:
-0.66
SPY:
1.72
PBYI:
-0.77
SPY:
2.33
PBYI:
0.91
SPY:
1.32
PBYI:
-0.52
SPY:
2.61
PBYI:
-0.99
SPY:
10.82
PBYI:
52.40%
SPY:
2.03%
PBYI:
77.71%
SPY:
12.75%
PBYI:
-99.40%
SPY:
-55.19%
PBYI:
-98.99%
SPY:
-1.05%
Returns By Period
In the year-to-date period, PBYI achieves a -8.52% return, which is significantly lower than SPY's 2.95% return. Over the past 10 years, PBYI has underperformed SPY with an annualized return of -35.00%, while SPY has yielded a comparatively higher 13.13% annualized return.
PBYI
-8.52%
-9.42%
2.76%
-55.07%
-25.70%
-35.00%
SPY
2.95%
3.78%
11.68%
23.68%
14.09%
13.13%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PBYI vs. SPY — Risk-Adjusted Performance Rank
PBYI
SPY
PBYI vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Puma Biotechnology, Inc. (PBYI) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PBYI vs. SPY - Dividend Comparison
PBYI has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.17%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBYI Puma Biotechnology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.17% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
PBYI vs. SPY - Drawdown Comparison
The maximum PBYI drawdown since its inception was -99.40%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for PBYI and SPY. For additional features, visit the drawdowns tool.
Volatility
PBYI vs. SPY - Volatility Comparison
Puma Biotechnology, Inc. (PBYI) has a higher volatility of 9.74% compared to SPDR S&P 500 ETF (SPY) at 3.45%. This indicates that PBYI's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.